Overview

Bioequivalence Study of Ziprasidone HCL Capsules, 20 mg Under Fasting Conditions

Status:
Completed
Trial end date:
2005-01-01
Target enrollment:
Participant gender:
Summary
The objective of this study is to compare the rate and extent of absorption of ziprasidone 20 mg capsules versus Geodon 20 mg capsules under fasting conditions.
Phase:
Phase 1
Details
Lead Sponsor:
Dr. Reddy's Laboratories Limited
Treatments:
Ziprasidone